2011 Volume 25 Issue 4 Pages 700-704
Japanese Pediatric Guideline for the Treatment and Management of Asthma was revised majorly in 2002, and restriction of usage of theophylline for younger children was stated from JPGL 2005. In 2008 revision, the point was that JPGL decided not to use the term "anti-allergy drug" any more. Anti-allergic drug contains many spectrum of drugs to treat allergy, such as anti-histamine, leukotirene receptor antagonist, etc. In other international guideline for asthma such as GINA, they have never used the term of "anti-allergic drug". It is a milestone for JPGL to exclude oral anti-allergic drug for the long management of bronchial asthma and to recommend leukotirene receptor antagonist and cromolyn only.
